SK3796A3 - Process for the synthesis of azetidinones - Google Patents
Process for the synthesis of azetidinones Download PDFInfo
- Publication number
- SK3796A3 SK3796A3 SK37-96A SK3796A SK3796A3 SK 3796 A3 SK3796 A3 SK 3796A3 SK 3796 A SK3796 A SK 3796A SK 3796 A3 SK3796 A3 SK 3796A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- group
- substituted
- lower alkyl
- benzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8935793A | 1993-07-09 | 1993-07-09 | |
PCT/US1994/007291 WO1995001961A1 (en) | 1993-07-09 | 1994-07-01 | Process for the synthesis of azetidinones |
Publications (1)
Publication Number | Publication Date |
---|---|
SK3796A3 true SK3796A3 (en) | 1997-02-05 |
Family
ID=22217215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK37-96A SK3796A3 (en) | 1993-07-09 | 1994-07-01 | Process for the synthesis of azetidinones |
Country Status (21)
Country | Link |
---|---|
US (1) | US5728827A (de) |
EP (1) | EP0707567B1 (de) |
JP (1) | JP2840452B2 (de) |
KR (1) | KR0176001B1 (de) |
CN (1) | CN1071745C (de) |
AT (1) | ATE205475T1 (de) |
AU (1) | AU681419B2 (de) |
CA (1) | CA2166784C (de) |
CZ (1) | CZ7696A3 (de) |
DE (1) | DE69428280T2 (de) |
DK (1) | DK0707567T3 (de) |
ES (1) | ES2160125T3 (de) |
FI (1) | FI960095A0 (de) |
HU (1) | HUT73237A (de) |
MX (1) | MX9405152A (de) |
NO (1) | NO306294B1 (de) |
NZ (1) | NZ268798A (de) |
PL (1) | PL312502A1 (de) |
PT (1) | PT707567E (de) |
SK (1) | SK3796A3 (de) |
WO (1) | WO1995001961A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
AR025144A1 (es) * | 1998-12-07 | 2002-11-13 | Schering Corp | Proceso para preparar azetidinonas, proceso para preparar compuestos intermediarios asi como dichos compuestos intermediarios |
US6207822B1 (en) | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
AU4343500A (en) * | 1999-04-16 | 2000-11-02 | Schering Corporation | Use of azetidinone compounds |
US20060287254A1 (en) * | 2001-01-26 | 2006-12-21 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
PT1413331E (pt) * | 2001-01-26 | 2007-12-18 | Schering Corp | Combinações do activador do receptor activado por proliferador do peroxisoma (ppar) fenofibrato e inibidor da absorção de esterol para indicações vasculares. |
CN1275949C (zh) * | 2001-03-28 | 2006-09-20 | 先灵公司 | 2-吖丁啶酮中间体化合物的对映体选择性合成 |
ATE345793T1 (de) * | 2001-09-21 | 2006-12-15 | Schering Corp | Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
US20030204096A1 (en) * | 2002-03-25 | 2003-10-30 | Schering Corporation | Enantioselective synthesis of azetidinone intermediate compounds |
GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
US7135556B2 (en) * | 2002-07-19 | 2006-11-14 | Schering Corporation | NPC1L1 (NPC3) and methods of use thereof |
WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
US7459442B2 (en) * | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7208486B2 (en) * | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CA2550215A1 (en) | 2003-12-23 | 2005-07-07 | Astrazeneca Ab | Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
JP2007516287A (ja) * | 2003-12-23 | 2007-06-21 | メルク エンド カムパニー インコーポレーテッド | 抗高コレステロール血症化合物 |
EP1723414A4 (de) * | 2004-01-16 | 2008-03-26 | Merck & Co Inc | Npc1l1 (npc3) und verfahren zur identifizierung seiner liganden |
DE102004025071B4 (de) * | 2004-05-21 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Diphenylazetidinon-Derivaten |
NZ551413A (en) | 2004-05-21 | 2009-07-31 | Sanofi Aventis Deutschland | Method for producing 1,4-diphenyl azetidinone derivatives |
MX2007007473A (es) * | 2004-12-20 | 2007-09-04 | Schering Corp | Procedimiento para la sintesis de azetidinonas. |
MX2008000115A (es) * | 2005-06-20 | 2008-03-18 | Schering Corp | Derivados de piperidina utiles como antagonistas de histamina h3. |
SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
WO2007100807A2 (en) | 2006-02-24 | 2007-09-07 | Schering Corporation | Npc1l1 orthologues |
TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
WO2008030382A1 (en) * | 2006-09-05 | 2008-03-13 | Schering Corporation | Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
WO2008032338A2 (en) * | 2006-09-11 | 2008-03-20 | Manne Satyanarayana Reddy | Improved process for the preparation of ezetimibe and its intermediates |
CN101679236B (zh) | 2007-01-24 | 2013-03-06 | 克尔克公司 | 依泽替米贝的制备方法和其的衍生物 |
WO2010113175A2 (en) | 2009-04-01 | 2010-10-07 | Matrix Laboratories Ltd | Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe |
CN104803858B (zh) * | 2014-01-23 | 2019-03-01 | 东莞东阳光科研发有限公司 | 一种制备四丁基氟化铵三水合物的方法 |
IL295281A (en) | 2020-02-07 | 2022-10-01 | Gasherbrum Bio Inc | Heterocyclic glp-1 agonists |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0333268A1 (de) * | 1988-03-18 | 1989-09-20 | Merck & Co. Inc. | Verfahren zur Synthese eines chiralen 3-beta-Wasserstoff-(3R) 4-aroyloxyazetidinons |
US4876365A (en) * | 1988-12-05 | 1989-10-24 | Schering Corporation | Intermediate compounds for preparing penems and carbapenems |
US4983597A (en) * | 1989-08-31 | 1991-01-08 | Merck & Co., Inc. | Beta-lactams as anticholesterolemic agents |
US5085473A (en) * | 1990-10-09 | 1992-02-04 | Yuhe Yang | Air actuated car curtain device |
HUT67341A (en) * | 1991-07-23 | 1995-03-28 | Schering Corp | Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof |
-
1994
- 1994-07-01 WO PCT/US1994/007291 patent/WO1995001961A1/en active IP Right Grant
- 1994-07-01 PT PT94921407T patent/PT707567E/pt unknown
- 1994-07-01 AU AU72146/94A patent/AU681419B2/en not_active Ceased
- 1994-07-01 HU HU9503748A patent/HUT73237A/hu unknown
- 1994-07-01 SK SK37-96A patent/SK3796A3/sk unknown
- 1994-07-01 CA CA002166784A patent/CA2166784C/en not_active Expired - Fee Related
- 1994-07-01 NZ NZ268798A patent/NZ268798A/en unknown
- 1994-07-01 DK DK94921407T patent/DK0707567T3/da active
- 1994-07-01 AT AT94921407T patent/ATE205475T1/de active
- 1994-07-01 CZ CZ9676A patent/CZ7696A3/cs unknown
- 1994-07-01 ES ES94921407T patent/ES2160125T3/es not_active Expired - Lifetime
- 1994-07-01 DE DE69428280T patent/DE69428280T2/de not_active Expired - Lifetime
- 1994-07-01 PL PL94312502A patent/PL312502A1/xx unknown
- 1994-07-01 JP JP7504054A patent/JP2840452B2/ja not_active Expired - Fee Related
- 1994-07-01 US US08/578,594 patent/US5728827A/en not_active Expired - Lifetime
- 1994-07-01 CN CN94192732A patent/CN1071745C/zh not_active Expired - Fee Related
- 1994-07-01 KR KR1019960700068A patent/KR0176001B1/ko not_active IP Right Cessation
- 1994-07-01 EP EP94921407A patent/EP0707567B1/de not_active Expired - Lifetime
- 1994-07-06 MX MX9405152A patent/MX9405152A/es not_active IP Right Cessation
-
1996
- 1996-01-08 NO NO960083A patent/NO306294B1/no not_active IP Right Cessation
- 1996-01-09 FI FI960095A patent/FI960095A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0707567A1 (de) | 1996-04-24 |
EP0707567B1 (de) | 2001-09-12 |
CA2166784C (en) | 2001-12-11 |
JP2840452B2 (ja) | 1998-12-24 |
HU9503748D0 (en) | 1996-02-28 |
ES2160125T3 (es) | 2001-11-01 |
NO306294B1 (no) | 1999-10-18 |
CN1126989A (zh) | 1996-07-17 |
PT707567E (pt) | 2002-01-30 |
NZ268798A (en) | 1997-01-29 |
CA2166784A1 (en) | 1995-01-19 |
FI960095A (fi) | 1996-01-09 |
MX9405152A (es) | 1995-01-31 |
NO960083L (no) | 1996-03-04 |
AU681419B2 (en) | 1997-08-28 |
CZ7696A3 (en) | 1996-04-17 |
AU7214694A (en) | 1995-02-06 |
CN1071745C (zh) | 2001-09-26 |
FI960095A0 (fi) | 1996-01-09 |
HUT73237A (en) | 1996-07-29 |
KR960703853A (ko) | 1996-08-31 |
ATE205475T1 (de) | 2001-09-15 |
DE69428280T2 (de) | 2002-06-13 |
KR0176001B1 (ko) | 1999-03-20 |
NO960083D0 (no) | 1996-01-08 |
DK0707567T3 (da) | 2001-11-26 |
PL312502A1 (en) | 1996-04-29 |
JPH08507085A (ja) | 1996-07-30 |
US5728827A (en) | 1998-03-17 |
DE69428280D1 (de) | 2001-10-18 |
WO1995001961A1 (en) | 1995-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK3796A3 (en) | Process for the synthesis of azetidinones | |
US6093812A (en) | Process for the stereospecific synthesis of azetidinones | |
JP3145993B2 (ja) | 抗腫瘍化合物及びその調製方法 | |
US5561227A (en) | Process for the stereospecific synthesis of azetidinones | |
JPH03176468A (ja) | イソインドロン誘導体 | |
KR950013767B1 (ko) | 키랄성 아제티디논 화합물 및 이의 제조방법 | |
EP0336369A1 (de) | 3-Acylamino-1-[[[(substituierte Sulfonyl)amino]carbonyl]amino]2-azetidinone | |
IE55839B1 (en) | Azetidine compounds | |
US5804577A (en) | Cephalosporin derivatives | |
US4559333A (en) | Hydrazone substituted penems | |
EP0001715A2 (de) | Azetidinon Antibiotika und ihre pharmazeutischen Präparate und Verwendung | |
WO1996016067A1 (en) | Silylation process | |
FI83959B (fi) | Foerfarande foer framstaellning av antibiotiskt aktiva 1-karba-(1-detia) cefalosporinderivat. | |
KR880001989B1 (ko) | 펜엠 화합물의 제조방법 | |
JPS61176563A (ja) | 4,4‐ジアルキル‐2‐アゼチジノン類の製造法 | |
US4587241A (en) | Heterocyclic substituted penems | |
JP2696807B2 (ja) | カルバペネム誘導体の製法 | |
JPS59134796A (ja) | 6−アミノペニシラン酸のテトラアルキルアンモニウム塩を用いる6−アミノペニシラン酸エステルの製造法 | |
JP3315007B2 (ja) | ピリジルオキシブチニルアミン誘導体 | |
US5554773A (en) | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists | |
JPH0273057A (ja) | カルバペネム系抗生物質合成用中間体の製造法 | |
US20060281918A1 (en) | Resolution of enantiomeric mixtures of beta-lactams | |
GB2276166A (en) | Benzimidazoles as angiotensin II antagonists | |
JPH0572396B2 (de) | ||
JP2001514169A (ja) | β−メチルカルバペネム中間体の製造 |